Clinical Outcomes Between Pulsatile and Non-Pulsatile Flow During Cardiopulmonary Bypass

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07009730

Enrollment

Registered

2025-06-08

Start date

2019-07-23

Completion date

2020-07-23

Last updated

2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Cardiac Surgery Requiring Cardiopulmonary Bypass

Brief summary

The aim of this prospective, randomized study was to compare clinical outcomes of Pulsatile and non-pulsatile flow during Cardiopulmonary Bypass.

Interventions

PROCEDUREBypassing Agents

Cardiopulmonary bypass surgery, pulsatile flow

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patients undergoing Atrial Septal Defect closure and Mitral Valve replacement

Exclusion criteria

* • Moderate and severe LVEF * • Patient with bleeding dysfunction;AKI ;deranged liver dysfunction\\ * • Patient/Surrogate decision maker not giving written informed consent

Design outcomes

Primary

Measure	Time frame	Description
ICU Length of Stay	12 months	Measured in days from ICU admission to ICU discharge

Secondary

Measure	Time frame	Description
Duration of Cardiopulmonary Bypass (CPB)	12 months	Measured in minutes from initiation to termination of bypass

Countries

Nepal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026